HemoCue AB is a multinational corporation targeted on manufacturing point-of-care analysis

instruments for medical treatment. Their main product, the DM 201, is outdated and has big

issues gaining new market shares. For example, no medical treatment center in Sweden uses

DM 201 frequently. The project of developing a new instrument to replace it was assigned

two students at the development engineering program at Halmstad University. The project

also included integration of the new platform for DM 202 to HemoCue AB:s remaining

products.

The project began by defining the different technical areas concerned. By identifying six big

technical areas and reaching a technical height within these areas the project group was able

to combine the new knowledge and assemble them to a satisfying result. The project group

developed a new instrument with a 50 % decreased volume compared to the DM 201. The

components are carefully selected to match the technical progress in the medical treatment

business over the past years. The original project also resulted in a side project containing a

new cuvette unit which is decreased by 75 % compared with today’s unit. This new cuvette

unit also performs more accurate analysis. When the goals where reached for DM 202, the

project group started to integrate useful components into the remaining product range. To

make this possible the group had to redesign all the remaining instruments both internal and

external.

The superior work of the project group has resulted in a completely new product range for

HemoCue AB. Consisting of intelligent, powerful instrument that will be very attractive on

the market.